AnalystsMichael OkunewitchMichael Okunewitch's Stock Forecasts
AnalystsMichael Okunewitch
Analyst Ranking
Bottom 7%
#4692 out of 5020 analysts
Average Return
-7.43%
Win Rate
27%7 out of 26
Risk vs Reward
Poor
Good
Michael Okunewitch's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Lexaria Bioscience CorpLEXX | +215.61% | $0.87 | $2.73 | 2023-07-21 - 2024-07-19 | Strong Buy |
Anebulo Pharmaceuticals IncANEB | +147.52% | $1.01 | $2.50 | 2025-05-15 - 2025-09-17 | Strong Buy |
Lineage Cell Therapeutics IncLCTX | +139.66% | $0.58 | $1.39 | 2025-01-10 - 2025-09-17 | Strong Buy |
Citius Oncology IncCTOR | +89.36% | $0.94 | $1.78 | 2024-11-27 - 2025-09-17 | Strong Buy |
Radiopharm Theranostics LtdRADX | +77.50% | $4.00 | $7.10 | 2025-05-01 - 2025-09-17 | Strong Buy |
Michael Okunewitch Analyst Color
Get additional color on Michael Okunewitch's coverage of popular stocks
Michael Okunewitch's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Hcw Biologics IncHCWB | 2 | Strong Buy | $35.00 | +712.06% | Maintains | 4 months ago |
Anebulo Pharmaceuticals IncANEB | 2 | Strong Buy | $3.00 | +20.00% | Maintains | 4 months ago |
Radiopharm Theranostics LtdRADX | 1 | Strong Buy | $12.00 | +69.01% | Initiates Coverage On | 5 months ago |
Chemomab Therapeutics LtdCMMB | 2 | Strong Buy | $28.00 | +968.70% | Maintains | 7 months ago |
Mainz Biomed NvMYNZ | 1 | Strong Buy | $14.00 | +775.00% | Initiates Coverage On | 7 months ago |
Lineage Cell Therapeutics IncLCTX | 1 | Strong Buy | $3.00 | +115.83% | Maintains | 8 months ago |
Citius Oncology IncCTOR | 1 | Strong Buy | $3.00 | +68.54% | Initiates Coverage On | 10 months ago |
Ocugen IncOCGN | 1 | Strong Buy | $4.00 | +203.03% | Initiates Coverage On | a year ago |
Fibrobiologics IncFBLG | 1 | Strong Buy | $12.00 | +2,185.71% | Initiates Coverage On | a year ago |
Longeveron IncLGVN | 2 | Strong Buy | $6.00 | N/A | Maintains | a year ago |
Lexaria Bioscience CorpLEXX | 2 | Strong Buy | $12.00 | N/A | Maintains | 2 years ago |
Dmk Pharmaceuticals CorpDMKPQ | 1 | Strong Buy | $1.50 | N/A | Initiates Coverage On | 2 years ago |
Acrivon Therapeutics IncACRV | 1 | Strong Buy | $24.00 | N/A | Initiates Coverage On | 2 years ago |
Kiora Pharmaceuticals IncKPRX | 3 | Strong Buy | $18.00 | N/A | Maintains | 2 years ago |
Alzamend Neuro IncALZN | 1 | Strong Buy | $2,025.00 | N/A | Initiates Coverage On | 2 years ago |
Mediwound LtdMDWD | 1 | Strong Buy | $25.00 | N/A | Initiates Coverage On | 3 years ago |
Biorestorative Therapies IncBRTX | 1 | Strong Buy | $6.00 | N/A | Initiates Coverage On | 3 years ago |
Atlantic International CorpATLN | 1 | Strong Buy | $120.00 | N/A | Initiates Coverage On | 4 years ago |
Atai Life Sciences NvATAI | 1 | Strong Buy | $25.00 | N/A | Initiates Coverage On | 4 years ago |
Citius Pharmaceuticals IncCTXR | 1 | Strong Buy | $100.00 | N/A | Initiates Coverage On | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.